← Evidence map

TrialJCO precision oncology2025

PIK3CB Inhibitor GSK2636771 in Cancers With

Filip Janku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40865033